Comparing in-person and video self-compassion training for anxiety and depression
Compares in-person and video self-compassion training in adults with anxiety or depression.
Plain-language title generated from the registry record
Registry title: Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method
Key facts
- Where
- Washington D.C., United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT07028216, who can take part
Where in United States
- Georgetown University Medical CenterWashington D.C., United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Georgetown University
- Trial code
- NCT07028216
- Record updated
- 5 May 2026
- Original description
The study will compare the delivery of an 8-week Mindful Self-Compassion training, in-person against video-conference, on anxiety and depression symptom severity in patients with diagnosed anxiety disorders (generalized anxiety disorder, social anxiety disorder, and panic disorder) or major depressive disorder or dysthymia.Read full original descriptionShow less
Mindful Self-Compassion for Anxiety and Depression: A Randomized Comparison of In-Person Versus Videoconference Delivery
The study will compare the delivery of an 8-week Mindful Self-Compassion training, in-person against video-conference, on anxiety and depression symptom severity in patients with diagnosed anxiety disorders (generalized anxiety disorder, social anxiety disorder, and panic disorder) or major depressive disorder or dysthymia.
Inclusion: Must have a primary anxiety disorder (social anxiety disorder, generalized anxiety disorder, panic disorder, or agoraphobia) or major depressive disorder, current; Must score low on self-compassion, as measured by the self-compassion scale; Must understand study procedure and willing to participate in all testing visits, and treatment as assigned; Must be able to give informed consent to the study procedures.
Exclusion: Subjects taking some psychiatric medication such as barbiturates or antipsychotics. Sleep medications and some anti-depressants will be allowed, if the subject has been taken at stable dose 8 weeks prior to baseline and the patient plans to continue at the same dose through the trial; Concurrent psychotherapy initiated within 1 month of screen interview, or ongoing psychotherapy of any duration directed specifically toward the treatment of anxiety (such as Cognitive Behavioral Therapy); Comorbid psychiatric disorder other than anxiety or depression, such as psychotic disorder, obsessive compulsive disorder, eating disorders (i.e., anorexia and bulimia), bipolar disorder; developmental or organic mental disorders; and current (past 6 months) substance use disorders and current post-traumatic stress disorder as assessed by clinician at screening visit; A serious medical condition that may result in surgery or hospitalization; A history of head trauma causing prolonged loss of consciousness, or ongoing cognitive impairment; Individuals with a medical condition (i.e., epilepsy) that may be exacerbated by study treatment, as determined by a study physician or nurse practitioner based on history, physical, and/or labs; Inability to understand study procedures or informed consent process, or significant personality dysfunction likely to interfere with study participation (assessed during the clinical interview); Subjects who will be non-compliant with the study procedures. This may include planned travel out of town; Individuals who have completed a course of MSC or an equivalent meditation training in the last year; Individuals reporting significant active suicidal ideation or suicidal behaviors within the past year; Adults unable to consent; Pregnant women; Prisoners.